Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Intensity Conditioning HCT for High-Risk Pediatric Hematologic Malignancies
NCT00795132Phase 2Completed
- Sponsor
- University of Utah
- Start
- Apr 2004
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, fludarabine, antithymocyte globulin rabbit in acute leukemia, B-cell chronic lymphocytic leukemia (B-CLL), myelodysplastic syndrome (MDS), lymphoma, sponsored by University of Utah. Started Apr 2004; status: completed.
02
Drugs
busulfanfludarabineantithymocyte globulin rabbit
03
Conditions
acute leukemiaB-cell chronic lymphocytic leukemia (B-CLL)myelodysplastic syndrome (MDS)lymphoma
Beyond the preview
Go deeper on NCT00795132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795132.